@article{article, title = {{Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC 鈥� The ETOP/EORTC SPLENDOUR and AMGEN-249 trials}}, publisher = {{Elsevier BV}}, url = {{}}, year = {{2021}}, month = {{9}}, author = {{Peters S and Danson S and Ejedepang D and Dafni U and Hasan B and Radcliffe H-S and Bustin F and Crequit J and Coate L and Guillot M and Surmont V et al}}, doi = {{10.1016/j.lungcan.2021.09.002}}, volume = {{161}}, journal = {{Lung Cancer}}, pages = {{76-85}}, note = {{Accessed on 2025/05/06}}}